About the Company

Tavanta is advancing late-stage compounds with near-term commercial potential. Our current focus areas are anal fissure and prostate cancer.

Anal Fissure

An anal fissure can cause debilitating pain that severely disrupts daily life. Although calcium-channel blockers are the number-one recommended standard of care, they are only available through compounding pharmacies, which pose significant barriers to insurance coverage. Patients need a more reliable, comfortable, and insurance-friendly treatment option.

Prostate Cancer

Abiraterone acetate is an established cornerstone in prostate cancer treatment. However, its current delivery format involves a high pill burden and strict fasting requirements. By eliminating these physical barriers, we can offer a more accessible, patient-friendly treatment that achieves the same clinical outcomes.